Xaliproden
Talk0
31,736pages on
this wiki
this wiki
|
Xaliproden chemical structure | |
| 1-(2-naphthalen-2-ylethyl)-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine IUPAC name | |
| CAS number 135354-02-8 | ATC code |
| PubChem 128919 | DrugBank [1] |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 381.433 g/mol |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Pregnancy category | |
| Legal status | |
| Routes of administration | |
Xaliproden is a drug which has been proposed for use in the treatment of Alzheimer's disease.[1]
References
Edit
- ↑ Lemaire L, Fournier J, Ponthus C, Le Fur Y, Confort-Gouny S, Vion-Dury J, Keane P, Cozzone P (2002). Magnetic resonance imaging of the neuroprotective effect of xaliproden in rats.. Invest Radiol 37 (6): 321-7. PMID 12021588.
